Parallax Volatility Advisers, L.P. Affimed N.V. Put Options Transaction History

Parallax Volatility Advisers, L.P.

2 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q4 2018 Feb 14, 2019	SELL	$2.82 - $4.67 $141,000 - $233,500	-50,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$1.45 - $6.15 $72,500 - $307,500	50,000 New	50,000 $217,000

1.09M

Ticker AFMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,339,008
Market Cap $185M
Description
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.